Workflow
个性化中药临方制剂
icon
Search documents
毛利率秒杀行业龙头!东北中医连锁赴港IPO,好学老板正攻读名校MBA
Xin Lang Cai Jing· 2026-02-25 11:20
登录新浪财经APP 搜索【信披】查看更多考评等级 来自东北的民营中医诊所誉研堂,正加快脚步朝港交所走去。 1月27日,哈尔滨誉研堂中医门诊集团股份有限公司(下称"誉研堂")宣布进一步委任老虎证券为联席 整体协调人。 更早之前的1月16日,公司已向港交所主板递交上市申请,并委任招银国际及国元国际为联席整体协调 人。 短短半个月内迅速增设整体协调人,显示出公司推进IPO的迫切心态。 这家起家于哈尔滨的中医连锁机构,试图讲述一个关于民营中医规模化与标准化的资本故事。 来源:财通社 01 从东北一隅到北方连锁 誉研堂的故事起点并不宏大。其历史可以追溯至2015年,创始人郭阳通过投资并创立哈尔滨华新普健中 医药研究院进入中医药行业,主要从事草药膏剂及药物研究。 三年后,2018年7月,公司以"哈尔滨膏珍堂中医诊所有限公司"的名称成立,第一家诊所落地哈尔滨。 郭阳今年42岁,早年经历不详,本人较为低调神秘。招股书披露,其于医疗及健康科技行业拥有丰富经 验,曾长期担任哈尔滨华新普健医疗科技有限责任公司执行董事及经理。 如今他仍在持续学习,一边在国家开放大学就读,一边在中欧国际工商学院攻读MBA,预计于今年10 月从该商学院 ...
誉研堂递表港交所 招银国际和国元国际担任联席保荐人
Core Viewpoint - The company, Yuyantang, has submitted its prospectus to the Hong Kong Stock Exchange, with Zhuhai International and Guoyuan International acting as joint sponsors, focusing on a "full lifecycle diagnosis and treatment model" based on Traditional Chinese Medicine (TCM) principles [1] Group 1: Business Model - The company operates on a "preventive treatment" philosophy, covering four stages: "pre-disease, desire for disease, existing disease, and post-recovery," providing integrated personalized health solutions that include prevention, adjustment, treatment, and maintenance [1] - Yuyantang employs a strict model of "offline initial diagnosis and online follow-up," ensuring all patients complete diagnostic assessments at licensed offline institutions, while the online platform manages follow-ups, chronic disease care, and health management to ensure service continuity [1] Group 2: Market Position - According to a Frost & Sullivan report, Yuyantang ranks as the second-largest private chain TCM healthcare service provider in Northern China by total revenue from TCM outpatient services and clinics as of 2024, and it ranks first in revenue from medicinal pastes [1] - The company boasts the highest customer repurchase rate among private chain TCM healthcare service providers, achieving a repurchase rate of 81.1% for the nine months ending September 30, 2025 [1] Group 3: Infrastructure and Expertise - Yuyantang has established a network of 48 self-built and operated licensed medical institutions in Northern China, all managed through a unified cloud-based healthcare information system (HIS) for digital management [1] - The company offers personalized TCM prescriptions, including decoctions, pills, powders, and pastes, and possesses proprietary non-heritage pastes and several in-house developed formulations as protected therapeutic assets [1] - Yuyantang employs 292 full-time medical professionals, with a research committee comprising 98 experts, integrating knowledge from both internal medical teams and external research collaborators [1]